# NAROPIN

NDC: 0404-9924
Generic name: ropivacaine hydrochloride
Labeler / Manufacturer: Henry Schein, Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: New Drug Application (innovator)
Dosage form: INJECTION, SOLUTION
Routes: EPIDURAL, INFILTRATION, PERINEURAL
Marketing started: 20220113

FDA application: NDA020533

## Active ingredients

- ROPIVACAINE HYDROCHLORIDE: 5 mg/mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"0404-9924"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=0404-9924
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=6a2f1f6d-026f-4f39-aee0-5b75b8eb5c02